Efter indgift bør patienten holdes under observation i mindst en halv time, da erfaringer viser, at størstedelen af bivirkningerne indtræffer inden for dette tidsrum.
After the administration, the patient should be kept under observation for at least half an hour, since experience shows that the majority of undesirable effects occur within this time.